Will you be part of our future as an investor, or do you have a question about Cassiopea? Please contact us at email@example.com for general inquiries.
For inquiries regarding press releases and media relations for Cassiopea please contact firstname.lastname@example.org.
Sign up to stay informed about now FDA-approved WINLEVI® (clascoterone) cream 1%, our first-in-class topical treatment.
Communications about WINLEVI are intended for US healthcare professionals only.